跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Stacef Plus - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Stacef Plus
Approved
STANDARD
Stacef Plus
Inject Care Parenterals Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
a60aa0e2b190c011
Company
Inject Care Parenterals Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
a60aa0e2b190c011
Drug Approval Philippines Name
Stacef Plus
Product Name
Stacef Plus
Registration Number
DR-XY45329
Brand Name
Stacef Plus
Generic Name
Ceftriaxone (as sodium) + Sulbactam (as sodium)
Dosage Form
Powder For Injection (I.M./I.V.)
Dosage Strength
1 g/ 500 mg
Manufacturer
Inject Care Parenterals Pvt. Ltd.
Trader
India
Importer
Stallion Laboratories Pvt. Ltd.
Distributor
Ambica International Corp.
Issuance Date
28 March 2023
Expiry Date
28 March 2028
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
a60aa0e2b190c011
Type
Standard
Back to Philippines FDA Approvals